PUBLISHER: BCC Research | PRODUCT CODE: 1119777
PUBLISHER: BCC Research | PRODUCT CODE: 1119777
The global market for insulin drug and delivery technologies is estimated to increase from $55.8 billion in 2022 to reach $88.9 billion by 2027, at a compound annual growth rate (CAGR) of 9.8% from 2022 through 2027.
The global market for syringe delivery technologies is estimated to increase from $24.3 billion in 2022 to reach $37.0 billion by 2027, at a CAGR of 8.7% from 2022 through 2027.
The global market for smart insulin pen delivery technologies is estimated to increase from $4.2 billion in 2022 to reach $7.7 billion by 2027, at a CAGR of 12.6% from 2022 through 2027.
The current report will provide an in-depth look at the insulin drug and delivery technologies market. This report analyzes the market trends of insulin drug and delivery technologies with data from 2021, estimates from 2022, projections of compound annual growth rates through 2027 (forecast period 2022-2027), and regional markets of the insulin drug and delivery technologies. This report will highlight the current and future market potential of insulin drug and delivery technologies along with a detailed analysis of the competitive environment. Regulatory scenarios, drivers, restraints and opportunities will be covered in the current report. The report also covers market projections for 2026 and market share for key market players.
In this report, the market has been segmented based on device type, insulin type and geographic region. Device types include syringes, insulin pens, insulin pumps, smart pens and others. Insulin types include long-acting, rapid-acting, premixed insulins, intermediate-acting and short-acting.
Geographic regions covered include North America, Europe, Asia-Pacific and the rest of the world (RoW). Individual countries covered include the U.S., Germany, the U.K., Italy, France, Japan, China and India.
Figure A : Timeline of Major Insulin Breakthroughs